Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Rehabilitation of COVID-19 patients with cardiovascular disease

DOI: https://doi.org/ 10.29296/25879979-2022-02-10
Download full text PDF
Issue: 
2
Year: 
2022

S. A. Masyukov «Expert Clinic» Tver, Schweinikov’s avenue, 1

Introduction. It has been shown that new coronavirus infection has the most severe course in patients with cardiovascular diseases. It is noted that the issues of rehabilitation of patients with COVID - 19 and cardiovascular pathology are very relevant and need additional study. Objective of the study. To study literature data concerning the tactics of management and rehabilitation in patients with COVID-19 and cardiovascular diseases. Material and methods. 12 publications devoted to the study of management and rehabilitation tactics of COVID-19 patients were analyzed. Results. Objectives of medical rehabilitation of patients who underwent COVID-19 are presented. The key principles of medical rehabilitation of these patients are described. The peculiarities of rehabilitation measures depending on the severity of COVID-19 are presented. Conclusion. The disease COVID-19 is associated with the increased risk of cardiovascular and thromboembolic complications. Cardiovascular disease has been and remains the leading cause of death not only in our country, but in most countries of the world. Weakened attention to effective cardiovascular risk management in COVID-19 patients may lead to increased cardiovascular and overall mortality. Undoubtedly, COVID-19 patients should be involved in medical rehabilitation programs for faster and better recovery of functions of different systems (primarily respiratory and cardiovascular), improving quality of life, reducing the risk of adverse outcomes and disability
Keywords: 
COVID-19
cardiovascular diseases
rehabilitation
nurse
nursing
nursing practice

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Drapkina O.M., Drozdova L.Yu., Avdeev S.N. et al. Rendering outpatient and polyclinic medical care to patients with chronic diseases subject to dispensary observation in conditions of the COVID-19 pandemic. Interim guidelines. version 2. Cardiovascular therapy and prevention. 2021; 20 (8): 245–290.
  2. Bubnova M.G., Shlyakhto E.V., Aronov D.M. et al. New coronavirus infectious disease COVID-19: features of complex cardiac and respiratory rehabilitation. Consensus of experts of Russian Society for Cardiovascular Rehabilitation and Secondary Prevention (RosOKR), Russian Society of Cardiology (RSC), Russian Respiratory Society (RRS), Russian Union of Rehabilitationists (RUR), Russian Union of Nutritionists, Dietitians and Food Industry Specialists (ROSNDP). Russian Journal of Cardiology. 2021; 26 (5): 4487. DOI: 10.15829/1560-4071-2021-4487
  3. Chazova I. E. Mironova O. Yu. COVID-19 and cardiovascular diseases. Therapeutic Archives. 2020; 92 (9): 4–7. DOI: 10.26442/00403660.2020.09.000742.
  4. Martsevich S. Yu. Treatment of patients with COVID-19 and concomitant cardiovascular diseases: not to forget the principles of evidence-based medicine. Rational pharmacotherapy in cardiology. 2020; 16 (2): 273–276. DOI 10.20996/1819-6446-2020-04-11.
  5. Dedov D.V., Ivanov A.P., Elgardt I.A. Effect of electromechanical remodeling of the heart on the development of atrial fibrillation in patients with CHD and arterial hypertension. Russian Journal of Cardiology. 2011; 16 (4): 13–18.
  6. 6. Vakhnenko Y. V., Korotkikh A. V., Bagdasarian E. A. Myocardial damage in new coronavirus infection (literature review). Bulletin of Respiratory Physiology and Pathology. 2021; 82: 129 - 145. DOI 10.36604/1998-5029-2021-82-129-145.
  7. Alekian B. G., Boitsov S. A., Manoshkina E. M. et al. Myocardial revascularization in the Russian Federation for acute coronary syndrome in 2016-2020. Cardiology. 2021; 61 (12): 4–15. DOI 10.18087/cardio.2021.12. n1879.
  8. Barbarash OL, Karetnikova VN, Kashtalap VV, et al. A new coronavirus disease (COVID-19) and cardiovascular disease. Comprehensive problems of cardiovascular disease. 2020; 9 (2): 17–28. DOI 10.17802/2306-1278-2020-9-2-17-28.
  9. Dedov D.V. New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements. Phys. 2022; 33 (2): 47–49. DOI 10.29296/25877305-2022-02-07.
  10. Dedov D. V., Mazaev V. P., Ryazanova S. V. et al. Study of quality of life in interventional and conservative treatment of patients with stable angina pectoris at long-term follow-up. Cardiovascular therapy and prevention. 2014; 13 (5): 31–35. DOI 10.15829/1728-8800-2014-5-31-35
  11. Bubnova M.G., Aronov D.M. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonology. 2020; 30 (5): 688–699. DOI 10.18093/0869-0189-2020-30-5-688-699.
  12. Dedov D.V., Marchenko S.D. Vitamins, iron, zinc, selenium and selenium-containing drugs in the comprehensive prevention of complications and treatment of COVID-19 patients. Pharmacy. 2022; 71 (1): 5–9. DOI 10.29296/25419218-2022-01-01.